Save Newborn Lives By Screening For Deadly Immune Diseases By Pierre Mouchette | Bits-n-Pieces Researchers report that introducing widespread screening of newborns for a deadly disease called severe combined immunodeficiency, or SCID, followed by early treatment, boosted the five-year survival rate of children with the disorder from 73% before the advent of screening to 87%. Among children whose disease was suspected because of newborn screening rather than illness or family history, 92.5% survived five years or more after the treatment. These findings demonstrate for the first time that newborn screening facilitated the early identification of infants with SCID, leading to prompt treatment before life-threatening infections occurred and thereby increasing the proportion of children who survived to age five and beyond. Researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and colleagues led the study.
NIAID conducts and supports research at NIH, throughout the United States, and worldwide to study the causes of infectious and immune-mediated diseases and to develop better means of preventing, diagnosing, and treating these illnesses. News releases, fact sheets, and other NIAID-related materials are available on the NIAID website. For more information about NIH and its programs, visit www.nih.gov.
0 Comments
Your comment will be posted after it is approved.
Leave a Reply. |
BITS-N-PIECES
This page provides articles on Life and Life-Health on Mondays and Wednesdays, about your best friends, Cats, and Dogs, and then on Fridays on Environmental issues. DIGITAL DIGESTS
For in-depth information on topics of interest in the DIGITAL DIGESTs, click here. Archives
September 2023
|